Voyager Therapeutics Lands $45,000,000 Series A Funding

  • Feed Type
  • Date
    2/13/2014
  • Company Name
    Voyager Therapeutics
  • Mailing Address
    75 Sidney St. Cambridge, MA 02139
  • Company Description
    Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system. Our founders include scientific and clinical leaders in the fields of adeno-associated virus (AAV) gene therapy, expressed RNA interference and neuroscience.
  • Website
    http://www.voyagertherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $45,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Undisclosed